VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 110 filers reported holding VOYAGER THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $218,000 | +156.5% | 28,650 | -9.0% | 0.01% | +27.3% |
| Q4 2021 | $85,000 | +112.5% | 31,490 | +105.5% | 0.01% | +120.0% |
| Q3 2021 | $40,000 | -87.1% | 15,320 | -47.1% | 0.01% | -94.9% |
| Q3 2020 | $309,000 | -15.3% | 28,955 | 0.0% | 0.10% | -21.0% |
| Q2 2020 | $365,000 | -54.9% | 28,955 | -67.2% | 0.12% | -63.6% |
| Q1 2020 | $809,000 | -33.9% | 88,365 | +0.7% | 0.34% | -6.8% |
| Q4 2019 | $1,224,000 | +86.0% | 87,755 | +129.6% | 0.37% | +49.4% |
| Q3 2019 | $658,000 | -7.5% | 38,215 | +46.4% | 0.24% | -6.8% |
| Q2 2019 | $711,000 | +126.4% | 26,105 | +59.3% | 0.26% | +46.9% |
| Q1 2019 | $314,000 | – | 16,390 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 3,185,291 | $24,558,594 | 29.60% |
| EcoR1 Capital, LLC | 3,851,507 | $29,695,119 | 0.96% |
| ARMISTICE CAPITAL, LLC | 3,524,000 | $27,170,040 | 0.39% |
| EAM Investors, LLC | 123,818 | $954,637 | 0.19% |
| HARBOURVEST PARTNERS LLC | 61,776 | $476,293 | 0.16% |
| Diametric Capital, LP | 12,527 | $96,583 | 0.05% |
| Campbell & CO Investment Adviser LLC | 30,563 | $235,641 | 0.04% |
| CAXTON ASSOCIATES LP | 36,564 | $281,908 | 0.04% |
| FIDUCIARY TRUST CO | 252,303 | $1,945,256 | 0.04% |
| FARALLON CAPITAL MANAGEMENT LLC | 797,000 | $6,144,870 | 0.03% |